REAL-WORLD EFFECTIVENESS OF ATEZOLIZUMAB PLUS BEVACIZUMAB IN THE PATIENTS WITH HEPATOCELLULAR CARCINOMA: A MULTIINSTITUTIONAL COHORT IN TAIWAN

被引：0
|
作者：
Kuo, Y. C. [1 ]
Chang, K. C. [2 ]
Chen, H. Y. [3 ]
机构：
[1] Linkou Chang Gung Mem Hosp, Taoyuan, Tao, Taiwan
[2] Chang Gung Mem Hosp, Taoyuan, Taiwan
[3] Linkou Chang Gung Mem Hosp, Dept Pharm, Taoyuan, Tao, Taiwan
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD134
引用
收藏
页码：S475 / S475
页数：1
相关论文
共 50 条
  • [31] Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real-world practice
    Nakagawa, Miyuki
    Inoue, Masanori
    Ogasawara, Sadahisa
    Maruta, Susumu
    Okubo, Tomomi
    Itokawa, Norio
    Iino, Yotaro
    Obu, Masamichi
    Haga, Yuki
    Seki, Atsuyoshi
    Kikuchi, Yasuharu
    Kogure, Tadayoshi
    Yumita, Sae
    Ishino, Takamasa
    Ogawa, Keita
    Fujiwara, Kisako
    Iwanaga, Terunao
    Fujita, Naoto
    Sakuma, Takafumi
    Kojima, Ryuta
    Kanzaki, Hiroaki
    Koroki, Keisuke
    Taida, Takashi
    Kobayashi, Kazufumi
    Kiyono, Soichiro
    Nakamura, Masato
    Kanogawa, Naoya
    Kondo, Takayuki
    Nakagawa, Ryo
    Nakamoto, Shingo
    Muroyama, Ryosuke
    Chiba, Tetsuhiro
    Itobayashi, Ei
    Atsukawa, Masanori
    Koma, Yoshihiro
    Azemoto, Ryosaku
    Ito, Kenji
    Mizumoto, Hideaki
    Shinozaki, Masami
    Kato, Jun
    Kato, Naoya
    CANCER, 2023, 129 (04) : 590 - 599
  • [32] A Real-World Comparative Analysis of Atezolizumab Plus Bevacizumab and Transarterial Chemoembolization Plus Radiotherapy in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis
    Lee, Soon Kyu
    Kwon, Jung Hyun
    Lee, Sung Won
    Lee, Hae Lim
    Kim, Hee Yeon
    Kim, Chang Wook
    Song, Do Seon
    Chang, U. Im
    Yang, Jin Mo
    Nam, Soon Woo
    Kim, Seok-Hwan
    Song, Myeong Jun
    Kim, Ji Hoon
    Lee, Ahlim
    Yang, Hyun
    Bae, Si Hyun
    Han, Ji Won
    Nam, Heechul
    Sung, Pil Soo
    Jang, Jeong Won
    Choi, Jong Young
    Yoon, Seung Kew
    Shim, Dong Jae
    Kim, Doyoung
    Kim, Myungsoo
    CANCERS, 2023, 15 (17)
  • [33] Atezolizumab plus bevacizumab (A plus B) in patients with unresectable hepatocellular carcinoma (uHCC): Real-world experience from a US community oncology network
    Cosgrove, David
    Tan, Amie
    Osterland, Andrew
    Hernandez, Sairy
    Ogale, Sarika
    Mahrus, Sami
    Murphy, John
    Wilson, Thomas W.
    Patton, Gregory A.
    Loaiza-Bonilla, Arturo
    Singal, Amit G.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 447 - 447
  • [34] Real-World Systemic Treatment Patterns after Atezolizumab and Bevacizumab in Patients with Hepatocellular Carcinoma in the United States
    Singal, Amit G.
    Ozgurdal, Kirhan
    Fan, Xiaozhou
    Vassilev, Zdravko
    Pan, Xiaoyun
    Multani, Jasjit K.
    Chen, Chi-Chang
    Zhou, Zifan
    He, Jing
    Pisa, Federica
    CANCERS, 2023, 15 (23)
  • [35] Beyond atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma: overall efficacy and safety of tyrosine kinase inhibitors in a real-world setting
    Falette-Puisieux, Manon
    Nault, Jean-Charles
    Bouattour, Mohamed
    Lequoy, Marie
    Amaddeo, Giuliana
    Decaens, Thomas
    Di Fiore, Frederic
    Manfredi, Sylvain
    Merle, Philippe
    Baron, Aurore
    Locher, Christophe
    Pellat, Anna
    Coriat, Romain
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [36] Real-world data: Clinical characteristics and outcomes of patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab in Veteran Health Administration
    Alkadimi, Munaf
    Lucero, Kana
    Boyle, Lauren Diaz
    Fierro, Maria Elena
    Franklin, Kathleen
    Nooruddin, Zohra
    Mader, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [37] EARLY TUMOR RESPONSE AND SAFETY OF ATEZOLIZUMAB PLUS BEVACIZUMAB FOR PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA IN REAL WORLD PRACTICE
    Ando, Yuwa
    Kawaoka, Tomokazu
    Amioka, Kei
    Uchikawa, Shinsuke
    Kodama, Kenichiro
    Fujino, Hatsue
    Nakahara, Takashi
    Ono, Atsushi
    Murakami, Eisuke
    Yamauchi, Masami
    Imamura, Michio
    Aikata, Hiroshi
    HEPATOLOGY, 2021, 74 : 636A - 637A
  • [38] Real-world effectiveness and safety of ramucirumab in hepatocellular carcinoma patients: A retrospective study in Taiwan
    Hung, Min Hua
    Chang, Kaicheng
    Chen, Hui-Yu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 342 - 342
  • [39] Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings
    Ohama, Hideko
    Hiraoka, Atsushi
    Tada, Toshifumi
    Hirooka, Masashi
    Kariyama, Kazuya
    Tani, Joji
    Atsukawa, Masanori
    Takaguchi, Koichi
    Itobayashi, Ei
    Fukunishi, Shinya
    Tsuji, Kunihiko
    Ishikawa, Toru
    Tajiri, Kazuto
    Ochi, Hironori
    Yasuda, Satoshi
    Toyoda, Hidenori
    Ogawa, Chikara
    Nishimura, Takashi
    Hatanaka, Takeshi
    Kakizaki, Satoru
    Shimada, Noritomo
    Kawata, Kazuhito
    Naganuma, Atsushi
    Kosaka, Hisashi
    Matono, Tomomitsu
    Shibata, Hiroshi
    Aoki, Tomoko
    Tada, Fujimasa
    Nouso, Kazuhiro
    Morishita, Asahiro
    Tsutsui, Akemi
    Nagano, Takuya
    Itokawa, Norio
    Okubo, Tomomi
    Arai, Taeang
    Imai, Michitaka
    Koizumi, Yohei
    Nakamura, Shinichiro
    Iijima, Hiroko
    Kaibori, Masaki
    Hiasa, Yoichi
    Kudo, Masatoshi
    Kumada, Takashi
    ONCOLOGY, 2023, 101 (09) : 542 - 552
  • [40] Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: a real-world study
    D'Alessio, Antonio
    Weinmann, Arndt
    Galle, Peter
    Gaillard, Vincent
    Fulgenzi, Claudia Angela Maria
    Bettinger, Dominik
    Bengsch, Bertram
    Vogel, Arndt
    Balcar, Lorenz
    Scheiner, Bernhard
    Amara, Suneetha
    Muzaffar, Mahvish
    Naqash, Abdul Rafeh
    Personeni, Nicola
    Pressiani, Tiziana
    Sharma, Rohini
    Pinter, Matthias
    Cortellini, Alessio
    Rimassa, Lorenza
    Pinato, David J.
    JOURNAL OF HEPATOLOGY, 2022, 77 : S376 - S376
12345